Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab.
Journal Information
Full Title: Invest Ophthalmol Vis Sci
Abbreviation: Invest Ophthalmol Vis Sci
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Ophthalmology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure: Y. Hashimoto, None; S. Inoda, Chugai (F), Kowa (F), Novartis (F, R); H. Takahashi, Alcon (F), Bayer (F, R), Boehringer (F), Chugai (F), DeepEyeVision, Inc. (I), Kowa (F), Kyowakirin (R), Merck Sharp & Dohme (F), Novartis (F, R), Santen (F), Senju (F, R), Viatris (F); R. Takahashi, None; H. Yoshida, None; Y. Fujino, None; S. Sakamoto, Chugai (F); H. Kawashima, Alcon (F), Bayer (R), Chugai (F), DeepEyeVision (R), Heiwa-Iyou (R), HOYA (R), Kowa (F), Linical (R), Mitsubishi-Tanabe (F), Novartis (F, R), Santen (F, R), Senju (F, R), Zeiss (F); Y. Yanagi, Novartis (R), Santen (R)"
"Supported by a KAKENHI grant from the Japan Society for the Promotion of Science (21K09751). The funding organization had no role in study design; conducting the study; data collection, management, analysis, or interpretation; or preparation, review, or approval of this manuscript."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025